BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7669565)

  • 1. Prostate-specific membrane antigen: evidence for the existence of a second related human gene.
    Leek J; Lench N; Maraj B; Bailey A; Carr IM; Andersen S; Cross J; Whelan P; MacLennan KA; Meredith DM
    Br J Cancer; 1995 Sep; 72(3):583-8. PubMed ID: 7669565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.
    Rinker-Schaeffer CW; Hawkins AL; Su SL; Israeli RS; Griffin CA; Isaacs JT; Heston WD
    Genomics; 1995 Nov; 30(1):105-8. PubMed ID: 8595888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific membrane antigen.
    Fair WR; Israeli RS; Heston WD
    Prostate; 1997 Jul; 32(2):140-8. PubMed ID: 9215402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
    Heston WD
    Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
    Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the prostate-specific membrane antigen.
    Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
    Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
    Su SL; Huang IP; Fair WR; Powell CT; Heston WD
    Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
    Kawakami M; Nakayama J
    Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
    Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
    Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
    Carter RE; Feldman AR; Coyle JT
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):749-53. PubMed ID: 8570628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon.
    Israeli RS; Grob M; Fair WR
    Urol Clin North Am; 1997 May; 24(2):439-50. PubMed ID: 9126242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
    Noguchi M; Miyajima J; Itoh K; Noda S
    Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
    Naz RK; Santhanam R; Tyagi N
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1075-84. PubMed ID: 12372395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread.
    Renneberg H; Friedetzky A; Konrad L; Kurek R; Weingärtner K; Wennemuth G; Tunn UW; Aumüller G
    Urol Res; 1999; 27(1):23-7. PubMed ID: 10092150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
    O'Keefe DS; Bacich DJ; Heston WD
    Prostate; 2004 Feb; 58(2):200-10. PubMed ID: 14716746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.
    Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ
    Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of prostate-specific membrane antigen (PSMA). A neurocarboxypeptidase and membrane folate hydrolase].
    Heston WD
    Urologe A; 1996 Sep; 35(5):400-7. PubMed ID: 8999630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.